Koneksa recently participated in two milestone gatherings in the digital health community. Let’s talk about what they were and why they matter! The first was the first meeting of the…
Read More
Koneksa’s unique expertise in designing, developing, and deploying digital health technology (DHT)-enabled biomarkers in clinical trials, and our experience analyzing the corresponding data, can provide value to your product’s journey….
Earlier this month, the European Medicines Agency (EMA)’s Human Medicines Division issued “Questions and Answers: Qualification of Digital Technology-Based Methodologies to Support Approval of Medicinal Products.” The Q&A explains considerations...
Read More
